GlassScriptPhysician profile
Jenna K Timboe
NPI 1114362894
$1,326.46
in general payments reported to CMS, 2019-2025
19 companies · $513 in 2025
The $513 reported for 2025 was more than what 94% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.23 · 2020: $67.65 · 2021: $52.51 · 2022: $101 · 2023: $146 · 2024: $366 · 2025: $513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,024.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,024.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $234.14 | 2022-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $146.35 | 2019-2025 | Bexsero, Penmenvy |
| Merck Sharp & Dohme LLC | $146.03 | 2020-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Sanofi-Aventis U.S. LLC | $104.69 | 2024-2025 | |
| Kaleo, INC. | $89.69 | 2019-2023 | Auvi-Q |
| Sanofi Pasteur INC. | $89.15 | 2024-2025 | |
| Alk-Abello, INC | $83.92 | 2025 | Neffy |
| Mirum Pharmaceuticals, INC. | $80.02 | 2025 | Cholbam |
| Pfizer INC. | $74.72 | 2022-2025 | |
| Ars Pharmaceuticals Operations, INC. | $54.01 | 2025 | Neffy |
| Takeda Pharmaceuticals U.S.A., INC. | $40.61 | 2021-2023 | Elaprase |
| Cranial Technologies, INC | $33.54 | 2023-2025 | Doc Band |
| Neos Therapeutics, LP | $33.41 | 2025 | Cotempla Xr-Odt |
| Biomarin Pharmaceutical INC. | $23.13 | 2024 | Voxzogo 1.2mg |
| Vertical Pharmaceuticals, LLC | $21.98 | 2024 | Relexxii |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $19.56 | 2020 | |
| Collegium Pharmaceutical, INC. | $18.92 | 2025 | Jornay Pm |
| Dermira, INC. | $17.19 | 2019 | |
| Abbvie INC. | $15.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Timboe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.